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ABSTRACT 
The aim of this study was to establish the action of 1% tetracaine eye drops in 
combination with 0.1% phenylephrine in two different posologies and their effects on 
the eye compared to the 0.5% proparacaine drops in dogs. 22 animals were divided 
into two groups: TG (11 animals), received 1% tetracaine associated with 0.1% 
phenylephrine eye drops, one drop instilled in the left eye and two drops, with one-
minute interval between each, instilled in the right eye; PG (11 animals) received 
0.5% proparacaine eye drops following the same dosage. The average duration of 
the observed anesthetic action was 25 minutes for tetracaine and 15 minutes for 
proparacaine. The instillation of two drops increased anesthetic time in five minutes. 
No changes in intraocular pressure, pupil diameter and tear production was 
observed. The drops of tetracaine triggered chemosis in four (36.4%) animals. 
Topical anesthesia with proparacaine eye drops showed no adverse reactions and is 
thus recommended preferentially. 
Keywords: dog, topical anesthesia, eye, aesthesiometry, Cochet-Bonnet 
RESUMO 
Estudou-se a ação do colírio de tetracaína 1%, em associação com a fenilefrina 
0,1% em duas posologias diferenciadas, bem como seus efeitos oculares, 
comparando-a com a do colírio de proparacaína 0,5% em cães. Vinte e dois animais 
foram separados em dois grupos. Os do GT (n=11) receberam colírio de tetracaína 
1% associada à fenilefrina 0,1%, sendo uma gota instilada no olho esquerdo e duas 
gotas, com intervalo de um minuto entre cada, instiladas no olho direito; e os do GP 
(n=11), receberam colírio de proparacaína 0,5% seguindo a mesma posologia. A 
média de duração da ação anestésica observada foi de 25 minutos para a tetracaína 
e 15 minutos para a proparacaína. A instilação de duas gotas aumentou o tempo 
anestésico em cinco minutos. Não ocorreram alterações na pressão intra-ocular, no 
diâmetro pupilar e na produção lacrimal. O colírio de tetracaína desencadeou 
quemose em quatro (36,4%) animais. Na anestesia tópica do olho com proparacaína 
não ocorreram reações adversas sendo, assim, recomendada preferencialmente. 
Palavras-chave: cão, anestesia tópica, olho, estesiometria, Cochet-Bonnet
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INTRODUCTION 
Currently, in the topical ophthalmic anesthesia routine, proparacaine (also called 
proximetacaine) is the most widely used drug (Stiles et al., 2001). Its use is largely 
devoted to procedures such as tonometry, cytology of the cornea, removal of foreign 
body, intracameral and subconjunctival injections and surgical procedures 
(Lawrenson et al., 1998). Studies demonstrate and establish the efficacy and action 
duration of proparacaine in dogs (Herring et al., 2005), cats (Binder and Herring, 
2006), rabbits (Seabaugh et al., 1993), horses (Kalf et al., 2008) and men (Ezra and 
Allan, 2007). 
Besides the formulation of proparacaine 0.5%, tetracaine 1% eye drops are 
commercially available associated with 0.1% phenylephrine, a vasoconstrictor which 
aims to prolong the anesthetic effect. The tetracaine ophthalmic solution is widely 
used in veterinary medicine in Brazil, but few studies elucidate its action time and 
anesthetic efficacy in animals. Its ocular effects have been well established only in 
humans, which has slightly less anesthetic duration than the proparacaine, and 
moreover, is being associated with discomfort in the application (Bartfield et al., 
1994). The comparison of analgesic and ophthalmic effects, as well as the adverse 
reactions, of these two commercially available formulations of anesthetic eye drops in 
dogs will set up the indications for each drug for this species. 
The aim of this study was to determine and compare the anesthetic and the ocular 
effects of the two main commercial formulations, the drops of tetracaine 1%, in 
combination with phenylephrine 0.1% and 0.5% proparacaine eye drops in two 
different doses in dogs. 
  
MATERIALS AND METHODS 
A total of 22 healthy, male and female dogs of different breeds were randomly 
divided into two groups: TG animals (n=11) received tetracaine ophthalmic drops 1% 
associated with phenylephrine 0.1% (Colírio Anestésico®, Allergan Prod. Farm. Ltda, 
São Paulo, Brazil), being one drop instilled in the left eye (1) and two drops, with one-
minute interval between each, instilled in the right eye (2), and PG animals (n=11) 
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received proparacaine 0.5% eye drops (Anestalcon®, Alcon Lab. do Brasil Ltda, São 
Paulo, Brazil), being instilled a drop in the left eye (1) and two drops, with one-minute 
interval between each in the right eye (2). 
Before application (T0) corneal sensitivity was measured in both eyes, using a 
Cochet-Bonnet esthesiometer (Luneau Ophtalmologie, Chartres, France), noting the 
value of the longest length that triggered responses of retraction of the eyeball, eye 
movement or blinking, intraocular pressure, using Schiotz tonometer (Miltex, 
Tuttlingen, Germany), photomotor and consensual reflexes and the pupillary 
diameter with a digital caliper (Vonder Ferramentas, São Paulo, Brazil). The 
measurements continued after instillation of the drops, being recorded at 5 minutes 
intervals until 60 minutes (T5, T10, ... T60). The Schirmer tear test (Ophthalmos 
Farmacêutica, São Paulo, Brazil) was performed at T0 and repeated at T60 in order 
to detect changes in tear production. Attention has been focused to the occurrence of 
conjunctiva and cornea reactions as adverse effects to the application of eye drops. 
Statistical analysis was performed using the t test for comparisons between doses 
and between groups, except for data on reflexes and the occurrence of adverse 
reactions, for which was employed the chi-square test. 
 
RESULTS 
In the TG, six males and five females with a mean weight of 17.63±7.69kg, and in the 
PG four males and seven females with a mean weight of 11.81±8.62kg, were used. 
The average duration of anesthetic action observed was 25 minutes for tetracaine 
and 15 minutes for proparacaine, both times for the dosage using a single drop (Fig. 
1). 
In TG dogs no significant effect of treatment was observed, and in PG dogs, there 
was difference between the two doses at 25min (P<0.05), with an increase of 5min in 
time of action for the instillation of two drops. 
The PG had a faster onset of anesthetic activity than TG (T5; P<0.05), presenting 
anesthetic peaking at first evaluation at 5 minutes, regardless of dosage, while the 
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TG showed action peak at 10 and 15 minutes (1 and 2 drops, respectively), but a 
most fleeting action, regardless of the use of two drops (T35-T45; P<0.05) or a single 
drop (T25-T4; P<0.05). 
The intraocular pressure showed no differences between the doses in both groups 
(Fig. 2). When comparing the two eye drops, significant difference was observed with 
a lower eye pressure in the left eye (from T30 to T40; P<0.05) and in the right eye 
(T50-T55; P<0.05) for the TG. 
The groups did not present homogeneity in the pupil diameter size before the trial 
(T0), but differences in eye diameter (Fig. 3) and in the Schirmer tear test (Fig. 4) 
were not observed between groups or doses. 
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There was a decrease in fotomotor reflex in TG, three animals in both eyes and one 
animal only in the right eye, from 5 to 20 min (P<0.05), but no difference between the 
dosages. No decrease was observed in photomotor reflex on PG. 
The chemosis was seen as an adverse reaction in the TG, with three animals 
presenting bilaterally and one animal only in the right eye, with no difference between 
the dosages, but with significant difference between the groups (P<0.01). In PG no 
dog had chemosis. 
DISCUSSION AND CONCLUSIONS 
The cornea is a richly innervated tissue sensitively connected to the trigeminal nerve 
(Marfurt et al., 2001). Topical anesthetics work by promoting reversible blockade of 
sodium channels, preventing the spread of noxious stimuli from the cornea, 
conjunctiva and sclera (Page and Fraunfelder, 2009). 
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The rapid onset of action and the absence of tissue reaction popularized 
proparacaine, the most commonly used local anesthetic in ophthalmology. The onset 
time of proparacaine in dogs is approximately 30-60 seconds, its effects lasting 
between 10 to 20 minutes (Stiles et al., 2001). The instillation of two drops of 0.5% 
proparacaine, with a of one minute interval between each drop increased the time of 
action to 25 minutes (Herring et al., 2005). These results are similar to the ones of 
this experiment, with a median time of 15 minutes of action with the instillation of a 
drop and 20 minutes with two drops. The increase in duration of corneal anesthesia 
with the instillation of an additional drop is due, probably, to the mere increase of 
drug concentration in the cornea and surrounding tissues. 
In studies with other species, the average duration of proparacaine was 10 minutes 
(Bartfield et al., 1994) and 11 minutes (Weiss end Goren, 1991) in humans, 10 
minutes in rabbits (Seabaugh et al., 1993), 25 minutes in cats (Binder and Herring, 
2006) and 25 minutes in horses (Kalf et al., 2008). 
In a prospective, randomized double-blind clinical study comparing 0.5% 
proparacaine and tetracaine eye drops in persons, the anesthetic effect of 
proparacaine lasted 1.3 minutes longer than tetracaine (Bartfield et al., 1994). In this 
study, conversely, the comparison between two commercial formulations of 
commonly used anesthetic eye drops showed that tetracaine lasts about five minutes 
longer than proparacaine. This fact is due to the presence of phenylephrine 
associated with commercial tetracaine eye drops, a sympathomimetic, which induces 
local vasoconstriction, increasing the time of action of local anesthetic (Fukuda et al., 
1994). Since in Brazil there is only commercial solution containing 1% tetracaine 
associated with phenylephrine 0.1%, there was no interest in observing the effects of 
tetracaine alone. 
Local anesthetics desensitize the cornea, blocking the afferent component of the 
normal reflex, preventing the lacrimal and the third eyelid glands reflex secretion, 
reducing tear production (Hamor et al., 2000). 
According to Patton and Robinson (1975), decreased tear production afforded by the 
action of local anesthetics is responsible for increasing the bioavailability of the drug 
in the tissues of the cornea. This would be a possible explanation for the increase in 
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the time of anesthetic action found in the dosage of two drops. However, decreased 
tear production was not detected in either group, although it was compared to 
Schirmer test before instillation and after 60 minutes, when there was more activity of 
local anesthetics. 
There is a tendency to decrease intraocular pressure promoted by local anesthetics, 
probably by reducing the tension of the eyelids and auxiliary muscles of the eyeball 
(Ehongo et al., 2009). Unlike the study by Almubrad and Ogbuehi (2007) in humans, 
which found a significant reduction in intraocular pressure of 0.9mmHg two minutes 
after the instillation of proparacaine and 0.8mmHg after instillation of oxybuprocaine, 
in this study an increase of 0.9mmHg with the use of proparacaine and 0.5mmHg 
with tetracaine in intraocular pressure of the dogs after 5 minutes was found, with no 
significant statistic with the baseline. These results also differ from those observed in 
people with two other local anesthetics, betoxicaine and oxybuprocaine, in which a 
significant decrease in intraocular pressure was observed (Baudouin and Gastaud, 
1994). 
The increased thickness of the cornea can lead to a reading greater than the real 
tonometry (Ko et al., 2005). The instillation of one drop of proparacaine 0.5% is 
capable of increasing, though transient, corneal thickness (Herse and Siu, 1992; 
Nam et al., 2006), thus a greater reading of IOP is expected. 
The lower intraocular pressure observed with the use of tetracaine, when compared 
to proparacaine, just after the end of the therapeutic action of drugs may be due to 
the longer time of action of tetracaine, promoting greater recovery time of the tone of 
the eyelids and accessory muscles of the eyeball. 
Mydriasis or intraocular pressure alterations due to phenylephrine did not occur in 
this study, since its concentration when combined with tetracaine is 0.1%. 
Phenylephrine is widely used as a mydriatic in hospitalar routine made at 10%, 
concentration 100 times greater than that present in the anesthetic eye drops. Even 
at this higher concentration, it cannot promote adequate pupil dilation. The 10% 
concentration was not sufficient to promote mydriasis in cats (Trinavarat and 
Pituksung, 2009). Phenylephrine, however, even at concentrations as low as 0.1%, is 
a drug that can potentially trigger immediate or delayed allergic 
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blepharoconjunctivitis. Furthermore, in humans, tetracaine promotes more pain or 
discomfort than proparacaine (Bartfield et al., 1994; Shafi and Koay, 1998). 
There are minor structural differences between the two drugs. Tetracaine is a para-
aminobenzoic ester, while proparacaine is a meta-aminobenzoic ester. The 
implication of this subtle difference is not well defined, but it is known that the type of 
ester group may be linked to the development of allergic reactions (Lawrenson et al., 
1998). The higher the contrast of anesthetic eye drops pH with 7.4 (physiological 
pH), the greater the irritation of the ocular tissues (Lawrenson et al., 1998). 
Proparacaine has an average pH of 4.8 (Garcia-Arumi et al., 2007), while that of 
tetracaine is 4.54 (Weaver et al., 2003), which creates greater eye pain and adverse 
reactions. Both the ability of phenylephrine and tetracaine to trigger allergic reactions, 
since tetracaine has higher acidity, may explain the high incidence of chemosis 
animals in this group. 
There is a tendency to use the commercial solution of tetracaine in veterinary 
medicine in Brazil. One reason may be the need for refrigerated storage of 
proparacaine. This research, however, shows that proparacaine eye drop presents 
less tissue reaction and should be indicated both in diagnostic and surgical 
procedures. 
Briefly, the drops of tetracaine associated with phenylephrine promotes an action 10 
minutes longer than the application of proparacaine and two drops, with one-minute 
interval between drops, increases the duration anesthetic action in 5 minutes with 
proparacaine, but not with tetracaine. Topical anesthesia of the cornea with 
proparacaine had less adverse reactions. 
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